Morris & Dickson statement in response to a news story published this morning that says the DEA may attempt to revoke the company’s registration - Morris & Dickson
medicine

News & Insights

May 24, 2023

Morris & Dickson statement in response to a news story published this morning that says the DEA may attempt to revoke the company’s registration

Morris & Dickson takes seriously its commitment to ensure strict compliance with all DEA regulations. We strongly believe any attempt to revoke our registration would be unwarranted and unjustified.

Most importantly, any decision the DEA makes will not disrupt our operations. Business will continue as usual, and orders will continue to go out on time.

The company has invested millions to maintain contemporary compliance systems and processes, while also bringing in industry leading executives and compliance advisors.

While we hope to resolve this matter amicably, if the DEA attempts to revoke our license for previous actions, the company will vigorously appeal and seek a stay in federal court.

We are confident we will achieve an outcome that safeguards the supply chain for all of our healthcare partners and the communities they serve.